VELIN-PHARMA A/S: Financial statements 2024
CVR: 33026013
Source: annual report 2024, Danish Business Authority
01/06/2023 – 31/05/2024
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -3,444 and a net result of DKK 12,695,295 compared with DKK 5,547,264 the year before. Equity in the 2024 report amounted to DKK 49,484,024. The solvency ratio was 93.4%.
- Gross Profit
- DKK -3,444
- Profit/Loss
- DKK 12,695,295
- Equity
- DKK 49,484,024
- Total Assets
- DKK 52,976,085
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -3K | 12.7M | 49.5M | 0 |
| 2023 | - | 161K | 5.5M | 36.8M | 0 |
| 2022 | - | 440K | 3.1M | 31.2M | 0 |
| 2021 | - | 150K | 6M | 28.1M | 0 |
| 2020 | - | 279K | 3.5M | 22.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 27, 2024, Thomas Velin has joined the board of directors of VELIN-PHARMA A/S.
As of September 27, 2024, Niels Ebbe Valdal has left the board of directors of VELIN-PHARMA A/S.
As of September 26, 2024, Thomas Velin has left the board of directors of VELIN-PHARMA A/S.
About VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.